|
|
|
| Research progress on the epidemiology of pneumonia |
| ZHOU Xingyuan, HONG Hang, FANG Ting, XU Guozhang
|
| School of Public Health, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China |
|
|
|
|
Abstract Pneumonia is a common lower respiratory tract infection, which causes a large disease and economic burden worldwide, and is an important public health problem to be solved urgently. Based on review of publications pertaining to the epidemiology of pneumonia from 2013 to 2023, this article summaries the epidemiological characteristics and main influencing factors of pneumonia. It is found that the epidemiological characteristics of pneumonia vary in different areas; men, the elderly and children are the high-risk groups of pneumonia incidence and mortality; and age, smoking, alcohol consumption, air pollution, comorbidity and vaccination are the main factors affecting the incidence and mortality of pneumonia. Strengthening health education, reducing exposure to risk factors and promoting vaccination are recommended to lower the morbidity and mortality of pneumonia in susceptible populations.
|
|
Received: 05 May 2023
Revised: 28 July 2023
Published: 17 August 2023
|
|
|
|
|
|
[1] DISEASES G B D,INJURIES C.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet(London,England),2020,396(10258):1204-1222.
[2] SAFIRI S,MAHMOODPOOR A,KOLAHI A A,et al.Global burden of lower respiratory infections during the last three decades[J/OL].Front Public Health,2022,10[2023-07-28].https://doi.org/10.3389/fpubh.2022.1028525.
[3] REGUNATH H,OBA Y.Community-acquired pneumonia[M].Treasure Island(FL):StatPearls,2023.
[4] TORRES A,NIEDERMAN M S,CHASTRE J,et al.International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia:guidelines for the management of hospital-acquired pneumonia(HAP)/ventilator-associated pneumonia(VAP)of the European Respiratory Society(ERS),European Society of Intensive Care Medicine(ESICM),European Society of Clinical Microbiology and Infectious Diseases(ESCMID)and Asociacion Latinoamericana del Torax(ALAT)[J/OL].EurRespir J,2017,50(3)[2023-07-28].https://doi.org/10.1183/13993003.00582-2017.
[5] JAIN S,SELF W H,WUNDERINK R G,et al.Community-acquired pneumonia requiring hospitalization among U.S.adults[J].N Engl J Med,2015,373(5):415-427.
[6] RAMIREZ J A,WIEMKEN T L,PEYRANI P,et al.Adults hospitalized with pneumonia in the United States:incidence,epidemiology,and mortality[J].Clin Infect Dis,2017,65(11):1806-1812.
[7] LOPARDO G D,FRIDMAN D,RAIMONDO E,et al.Incidence rate of community-acquired pneumonia in adults:a population-based prospective active surveillance study in three cities in South America[J/OL].BMJ Open,2018,8(4)[2023-07-28].http://dx.doi.org/10.1136/bmjopen-2017-019439.
[8] TORRES A,CILLONIZ C,BLASI F,et al.Burden of pneumococcal community-acquired pneumonia in adults across Europe:a literature review[J].Respir Med,2018,137:6-13.
[9] AZMI S,ALJUNID S M,MAIMAITI N,et al.Assessing the burden of pneumonia using administrative data from Malaysia,Indonesia,and the Philippines[J].Int J Infect Dis,2016,49:87-93.
[10] FAGERLI K,ULZIIBAYAR M,SUURI B,et al.Epidemiology of pneumonia in hospitalized adults≥18 years old in four districts of Ulaanbaatar,Mongolia,2015-2019[J/OL].Lancet Reg Health West Pac,2023,30[2023-07-28].https://doi.org/10.1016/j.lanwpc.2022.100591.
[11] CHOI M J,SONG J Y,NOH J Y,et al.Disease burden of hospitalized community-acquired pneumonia in South Korea:analysis based on age and underlying medical conditions[J/OL].Medicine(Baltimore),2017,96(44)[2023-07-28].http://dx.doi.org/10.1097/MD.0000000000008429.
[12] GIULIANO K K,BAKER D,QUINN B.The epidemiology of nonventilator hospital-acquired pneumonia in the United States[J].Am J Infect Control,2018,46(3):322-327.
[13] BAKER D,QUINN B.Hospital acquired pneumonia prevention initiative-2:incidence of nonventilator hospital-acquired pneumonia in the United States[J].Am J Infect Control,2018,46(1):2-7.
[14] WICKY P H,MARTIN-LOECHES I,TIMSIT J F.HAP and VAP after Guidelines[J].Semin Respir Crit Care Med,2022,43(2):248-254.
[15] ROSENTHAL V D,JIN Z,MEMISH Z A,et al.Multinational prospective cohort study of rates and risk factors for ventilator-associated pneumonia over 24 years in 42 countries of Asia,Africa,Eastern Europe,Latin America,and the Middle East:findings of the International Nosocomial Infection Control Consortium(INICC)[J/OL].Antimicrob Steward Healthc Epidemiol,2023,3(1)[2023-07-28].https://doi.org/10.1017/ash.2022.339.
[16] PAPAZIAN L,KLOMPAS M,LUYT C E.Ventilator-associated pneumonia in adults:a narrative review[J].Intensive Care Med,2020,46(5):888-906.
[17] HU Y,HAN Y,YU C,et al.The hospitalization burden of all-cause pneumonia in China:a population-based study,2009-2017[J/OL].Lancet Reg Health West Pac,2022,22[2023-07-28].https://doi.org/10.1016/jlanwpc.2022.100443.
[18] 中华人民共和国国家卫生健康委员会.2022年中国卫生健康统计年鉴[M].北京:中国协和医科大学出版社,2022.
[19] ZHU Y G,TANG X D,LU Y T,et al.Contemporary situation of community-acquired pneumonia in China:a systematic review[J].J Transl Int Med,2018,6(1):26-31.
[20] SUN Y,LI H,PEI Z,et al.Incidence of community-acquired pneumonia in urban China:a national population-based study[J].Vaccine,2020,38(52):8362-8370.
[21] JIANG N,LI R,BAO J,et al.Incidence and disease burden of community-acquired pneumonia in southeastern China:data from integrated medical resources[J].Hum Vacc Immunother,2021,17(12):5638-5645.
[22] DING X,MA X,GAO S,et al.Effect of ICU quality control indicators on VAP incidence rate and mortality:a retrospective study of1267 hospitals in China[J/OL].Crit Care,2022,26(1)[2023-07-28].https://doi.org/10.1186/s13054-022-04285-6.
[23] ZHANG Y,YAO Z,ZHAN S,et al.Disease burden of intensive care unit-acquired pneumonia in China:a systematic review and meta-analysis[J].Int J Infect Dis,2014,29:84-90.
[24] JIAO J,YANG X Y,LI Z,et al.Incidence and related factors for hospital-acquired pneumonia among older bedridden patients in China:a hospital-based multicenter registry data based study[J/OL].Front Public Health,2019,7[2023-07-28].https://doi.org/10.3389/fpubh.2019.00221.
[25] DEB A,PODMORE B,BARNETT R,et al.Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in Germany[J/OL].Epidemiol Infect,2022,150[2023-07-28].https://doi.org/10.1017S0950268822001182.
[26] JAIN S,WILLIAMS D J,ARNOLD S R,et al.Community-acquired pneumonia requiring hospitalization among U.S.children[J].N Engl J Med,2015,372(9):835-845.
[27] Centers for Disease Control and Prevention.QuickStats:death rates*
from influenza and pneumonia(dagger)among persons aged≥65 years,by sex and age group-national vital statistics system,United States,2018[J/OL].MMWR,2020,69(40)[2023-07-28].https://www.cdc.gov/nchs/nvss/deaths.htm.
[28] GIBSON G J,LODDENKEMPER R,LUNDBACK B,et al.Respiratory health and disease in Europe:the new European Lung White Book[J].Eur Respir J,2013,42(3):559-563.
[29] 胡媛媛. 肺炎对老年患者免疫功能的影响[J].医疗装备,2017,30(4):106-107.
[30] MUTEPE N D,COCKERAN R,STEEL H C,et al.Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin[J].Eur Respir J,2013,41(2):392-395.
[31] ALMIRALL J,BLANQUER J,BELLO S.Community-acquired pneumonia among smokers[J].Arch Bronconeumol,2014,50(6):250-254.
[32] ALMIRALL J,SERRA-PRAT M,BOLIBAR I,et al.Passive smoking at home is a risk factor for community-acquired pneumonia in older adults:a population-based case-control study[J/OL].BMJ Open,2014,4(6)[2023-07-28].http://dx.doi.org/10.1136/bmjopen-2014-005133.
[33] AHN A,EDWARDS K M,GRIJALVA C G,et al.Secondhand smoke exposure and illness severity among children hospitalized with pneumonia[J].J Pediatr,2015,167(4):869-874.
[34] LEWIS S A,DORATT B M,SURESHCHANDRA S,et al.Ethanol consumption induces nonspecific inflammation and functional defects in alveolar macrophages[J].Am J Respir Cell Mol Biol,2022,67(1):112-124.
[35] SIMOU E,BRITTON J,LEONARDI-BEE J.Alcohol and the risk of pneumonia:a systematic review and meta-analysis[J/OL].BMJ Open,2018,8(8)[2023-07-28].http://dx.doi.org/10.1136/bmjopen-2017-022344.
[36] GUPTA N M,DESHPANDE A,ROTHBERG M B.Pneumonia and alcohol use disorder:implications for treatment[J].Cleve Clin J Med,2020,87(8):493-500.
[37] 关新朋,徐洪兵,方嘉堃,等.大气NOX和NO2急性暴露与儿童呼吸系统疾病门诊量的关联研究[J].预防医学,2023,35(3):185-189,195.
[38] ZHOU X,GUO M,LI Z,et al.Associations between air pollutant and pneumonia and asthma requiring hospitalization among children aged under 5 years in Ningbo,2015-2017[J/OL].Front Public Health,2022,10[2023-07-28].https://doi.org/10.3389/fpubh.2022.1017105.
[39] COLLABORATORS G L.Age-sex differences in the global burden of lower respiratory infections and risk factors,1990-2019:results from the Global Burden of Disease Study 2019[J].Lancet Infect Dis,2022,22(11):1626-1647.
[40] HAN X,ZHOU F,LI H,et al.Effects of age,comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia[J/OL].BMC Infect Dis,2018,18(1)[2023-07-28].https://doi.org/10.1186/s12879-018-3098-5.
[41] PELTON S I,SHEA K M,FARKOUH R A,et al.Rates of pneumonia among children and adults with chronic medical conditions in Germany[J/OL].BMC Infect Dis,2015,15[2023-07-28].https://www.altmetric.com/details/4703719.
[42] LUNA C M,PALMA I,NIEDERMAN M S,et al.The impact of age and comorbidities on the mortality of patients of different age groups admitted with community-acquired pneumonia[J].Ann Am Thorac Soc,2016,13(9):1519-1526.
[43] NIEDERMAN M S,FOLARANMI T,BUCHWALD U K,et al.Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes:a review of available evidence[J].Expert Rev Vaccines,2021,20(3):243-256.
[44] DOMNICH A,ARATA L,AMICIZIA D,et al.Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly:a systematic review and meta-analysis[J].Vaccine,2017,35(4):513-520.
[45] NAKASHIMA K,AOSHIMA M,OHFUJI S,et al.Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals:a randomized,open-label,non-inferiority trial[J].Hum Vacc Immunother,2018,14(8):1923-1930.
[46] HAMMOND A,HALLIDAY A,THORNTON H V,et al.Predisposing factors to acquisition of acute respiratory tract infections in the community:a systematic review and meta-analysis[J/OL].BMC Infect Dis,2021,21(1)[2023-07-28].https://doi.org/10.1186/s12879-021-06954-3.
[47] KLOMPAS M,BRANSON R,CAWCUTT K,et al.Strategies to prevent ventilator-associated pneumonia,ventilator-associated events,and nonventilator hospital-acquired pneumonia in acute-care hospitals:2022 update[J].Infect Control Hosp Epidemiol,2022,43(6):687-713. |
|
|
|
